Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 132,526 | 230,941 | 116,871 | 41,563 | 54,126 |
| Marketable Securities | 250,928 | 155,468 | 254,450 | 298,225 | 257,221 |
| Receivables | 38,000 | 34,266 | 35,641 | 31,203 | 31,658 |
| Inventories | 48,569 | 44,884 | 42,053 | 40,043 | 41,411 |
| TOTAL | $477,969 | $472,049 | $455,054 | $418,734 | $391,110 |
| Non-Current Assets | |||||
| PPE Net | 108,670 | 110,063 | 111,276 | 109,225 | 107,046 |
| Investments And Advances | 40,674 | 14,146 | 15,747 | 35,829 | 74,193 |
| Intangibles | 62,040 | 62,040 | 59,912 | 57,490 | 55,197 |
| Other Non-Current Assets | 0 | 747 | 692 | 759 | 825 |
| TOTAL | $211,384 | $186,996 | $187,627 | $203,303 | $237,261 |
| Total Assets | $689,353 | $659,045 | $642,681 | $622,037 | $628,371 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,368 | 13,795 | 14,260 | 14,913 | 14,658 |
| Accrued Expenses | 45,865 | 40,359 | 38,434 | 33,017 | 41,057 |
| TOTAL | $60,661 | $54,523 | $53,024 | $48,368 | $56,217 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 102 |
| Other Non-Current Liabilities | 307,466 | 303,256 | 299,144 | 295,148 | 292,671 |
| TOTAL | $307,466 | $303,256 | $299,144 | $295,148 | $292,671 |
| Total Liabilities | $368,127 | $357,779 | $352,168 | $343,516 | $348,888 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,230 | 41,114 | 40,960 | 40,732 | 40,712 |
| Common Shares | 41 | 41 | 41 | 41 | 41 |
| Retained earnings | -388,226 | -396,511 | -395,871 | -398,455 | -389,136 |
| Other shareholders' equity | -280 | -241 | -545 | -901 | -454 |
| TOTAL | $321,226 | $301,266 | $290,513 | $278,521 | $279,483 |
| Total Liabilities And Equity | $689,353 | $659,045 | $642,681 | $622,037 | $628,371 |